Wudy S, Mauche N, Huang J, Strauss M
Nervenarzt. 2025; .
PMID: 40042614
DOI: 10.1007/s00115-025-01807-9.
Baweja R, Faraone S, Childress A, Weiss M, Loo S, Wilens T
J Child Adolesc Psychopharmacol. 2024; 34(4):167-182.
PMID: 38686563
PMC: 11302246.
DOI: 10.1089/cap.2024.0022.
Reed E, Keller-Norrell P
Int J Mol Sci. 2023; 24(24).
PMID: 38139206
PMC: 10743742.
DOI: 10.3390/ijms242417377.
Wang T, Lee Y, Chung C, Sun C, Kang C, Wu G
Int J Womens Health. 2023; 15:1865-1882.
PMID: 38046265
PMC: 10693200.
DOI: 10.2147/IJWH.S430252.
Levine S, Rotstein A, Kodesh A, Sandin S, Lee B, Weinstein G
JAMA Netw Open. 2023; 6(10):e2338088.
PMID: 37847497
PMC: 10582792.
DOI: 10.1001/jamanetworkopen.2023.38088.
[Epidemiology, diagnostics and treatment of attention deficit-hyperactivity disorder (ADHD) in advanced age].
Praus P, Moldavski A, Alm B, Hennig O, Rosler M, Retz W
Nervenarzt. 2023; 94(11):1043-1049.
PMID: 37747504
PMC: 10620251.
DOI: 10.1007/s00115-023-01548-7.
Risk of neurodegenerative disease or dementia in adults with attention-deficit/hyperactivity disorder: a systematic review.
Becker S, Chowdhury M, Tavilsup P, Seitz D, Callahan B
Front Psychiatry. 2023; 14:1158546.
PMID: 37663597
PMC: 10469775.
DOI: 10.3389/fpsyt.2023.1158546.
From attention-deficit hyperactivity disorder to sporadic Alzheimer's disease-Wnt/mTOR pathways hypothesis.
Grunblatt E, Homolak J, Babic Perhoc A, Davor V, Knezovic A, Osmanovic Barilar J
Front Neurosci. 2023; 17:1104985.
PMID: 36875654
PMC: 9978448.
DOI: 10.3389/fnins.2023.1104985.
The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma.
Allami P, Heidari A, Rezaei N
Front Mol Biosci. 2023; 9:1083645.
PMID: 36660431
PMC: 9846545.
DOI: 10.3389/fmolb.2022.1083645.
Exploring the causal effects of genetic liability to ADHD and Autism on Alzheimer's disease.
Pagoni P, Dardani C, Leppert B, Korologou-Linden R, Davey Smith G, Howe L
Transl Psychiatry. 2022; 12(1):422.
PMID: 36182936
PMC: 9526708.
DOI: 10.1038/s41398-022-02150-2.
Real-World Evidence for the Association Between Pneumonia-Related Intensive Care Unit Stay and Dementia.
Wu C, Peng C, Chung C, Chien W, Tzeng N
Psychiatry Investig. 2022; 19(4):247-258.
PMID: 35500898
PMC: 9058270.
DOI: 10.30773/pi.2021.0277.
The Usage of Histamine Type 1 Receptor Antagonist and Risk of Dementia in the Elderly: A Nationwide Cohort Study.
Yang C, Chien W, Chung C, Lai C, Tzeng N
Front Aging Neurosci. 2022; 14:811494.
PMID: 35370616
PMC: 8972197.
DOI: 10.3389/fnagi.2022.811494.
Investigation of the Association Between History of Learning Disabilities and Primary Progressive Aphasia in Brazilian Portuguese Speakers.
Dos Reis T, Machado T, Caramelli P, Scornavacca F, Fernandez L, Beber B
Front Neurol. 2022; 13:703729.
PMID: 35295826
PMC: 8918792.
DOI: 10.3389/fneur.2022.703729.
ADHD and Neurodegenerative Disease Risk: A Critical Examination of the Evidence.
Becker S, Sharma M, Callahan B
Front Aging Neurosci. 2022; 13:826213.
PMID: 35145394
PMC: 8822599.
DOI: 10.3389/fnagi.2021.826213.
Contribution of vascular risk factors to the relationship between ADHD symptoms and cognition in adults and seniors.
Callahan B, Plamondon A, Gill S, Ismail Z
Sci Rep. 2021; 11(1):24276.
PMID: 34930996
PMC: 8688479.
DOI: 10.1038/s41598-021-03782-y.
Attention-deficit/hyperactivity disorder as a risk factor for dementia and mild cognitive impairment: a population-based register study.
Dobrosavljevic M, Zhang L, Garcia-Argibay M, Du Rietz E, Andershed H, Chang Z
Eur Psychiatry. 2021; :1-19.
PMID: 34924079
PMC: 8792867.
DOI: 10.1192/j.eurpsy.2021.2261.
Longitudinal Cognitive Performance of Older Adults With ADHD Presenting to a Cognitive Neurology Clinic: A Case Series of Change Up to 21 Years.
Callahan B, Shammi P, Taylor R, Ramakrishnan N, Black S
Front Aging Neurosci. 2021; 13:726374.
PMID: 34867269
PMC: 8634492.
DOI: 10.3389/fnagi.2021.726374.
Risk of Colorectal Cancer in Patients With Attention-Deficit Hyperactivity Disorder: A Nationwide, Population-Based Cohort Study.
Hu J, Lee C, Lin T, Chung C, Chen C, Chang P
Front Psychiatry. 2021; 12:537137.
PMID: 33613335
PMC: 7892783.
DOI: 10.3389/fpsyt.2021.537137.
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.
Faraone S, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove M
Neurosci Biobehav Rev. 2021; 128:789-818.
PMID: 33549739
PMC: 8328933.
DOI: 10.1016/j.neubiorev.2021.01.022.
Association between amphetamine-related disorders and dementia-a nationwide cohort study in Taiwan.
Tzeng N, Chien W, Chung C, Chang H, Kao Y, Liu Y
Ann Clin Transl Neurol. 2020; 7(8):1284-1295.
PMID: 32608133
PMC: 7448166.
DOI: 10.1002/acn3.51113.